Download video

Characterizing FDA’s Approach to Benefit-Risk Assessment throughout the Medical Product Life Cycle

2.6K views

Duke Margolis

5 years ago

Characterizing FDA’s Approach to Benefit-Risk Assessment throughout the Medical Product Life Cycle

Characterizing FDA’s Approach to Benefit-Risk Assessment throughout the Medical Product Life Cycle

Characterizing FDA’s Approach to Benefit-Risk Assessment throughout the Medical Product Life Cycle
6:09:16
Characterizing FDA’s Approach to Benefit-Risk Assessment throughout the Medical Product Life Cycle
by Duke Margolis
Introduction to Regulatory Science at the FDA
43:14
Introduction to Regulatory Science at the FDA
by Stanford
A Framework on the Presentation of Safety Risks Throughout the Product Lifecycle Overview Video
12:21
A Framework on the Presentation of Safety Risks Throughout the Product Lifecycle Overview Video
by TransCelerate BioPharma
Risk Basics for Medical Devices
23:18
Risk Basics for Medical Devices
by U.S. Food and Drug Administration
Application of Risk Management Principles for Medical Devices
24:25
Application of Risk Management Principles for Medical Devices
by U.S. Food and Drug Administration
Benefit-Risk Considerations in Drug Development (6\/14) REdI 2017
31:21
Benefit-Risk Considerations in Drug Development (6\/14) REdI 2017
by U.S. Food and Drug Administration
The FDA's Role in Gene Therapy
58:27
The FDA's Role in Gene Therapy
by National Organization for Rare Disorders (NORD)
The Game Has Changed Event Day #2!
The Game Has Changed Event Day #2!
by Dean Graziosi
Forum on International Regulatory Cooperation
5:07:31
Forum on International Regulatory Cooperation
by Administrative Conference of the United States
Benefit Risk-Analysis: Learning From a Method Proposed by the FDA
19:54
Benefit Risk-Analysis: Learning From a Method Proposed by the FDA
by Let's Talk Risk!
MDICx Series- Patient Centered Benefit-Risk Assessment 1\/22\/15
57:11
MDICx Series- Patient Centered Benefit-Risk Assessment 1\/22\/15
by MDIC - Medical Device Innovation Consortium
Division of Risk Management: Overview of Review Activities and REMS - Pharmacovigilance 2020
41:06
Division of Risk Management: Overview of Review Activities and REMS - Pharmacovigilance 2020
by U.S. Food and Drug Administration
Complex Product Characterization\/Analysis - Session 2A
34:41
Complex Product Characterization\/Analysis - Session 2A
by U.S. Food and Drug Administration
FDA Pharmaceutical Validation Guidance and ICH: What you must know
8:49
FDA Pharmaceutical Validation Guidance and ICH: What you must know
by cGMP Made Easy
ICH Q 12 A New Innovative approach to Product Life Cycle Management
1:11:55
ICH Q 12 A New Innovative approach to Product Life Cycle Management
by Pharma Best Practices Webinars
June 10, 2024 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee (PCNS)
7:26:41
June 10, 2024 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee (PCNS)
by U.S. Food and Drug Administration
Recent FDA Feedback Regarding Extractable and Leachable Testing
47:26
Recent FDA Feedback Regarding Extractable and Leachable Testing
by Nelson Labs
Communicating Benefit and Risk Information
4:16
Communicating Benefit and Risk Information
by U.S. Food and Drug Administration
Dawn Bardot - Advancing Medical Device Regulatory Science Throughout Total Product Life Cycle (2016)
13:27
Dawn Bardot - Advancing Medical Device Regulatory Science Throughout Total Product Life Cycle (2016)
by Focused Ultrasound Foundation - Symposium Programs
Benefit-Risk Assessments for Marketing Applications: Employing a Well-Structured \& Thorough Approach
54:24
Benefit-Risk Assessments for Marketing Applications: Employing a Well-Structured \& Thorough Approach
by MMS Holdings